The notices it replaced
- Reissues: PAR-24-238 Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,025,888 in first-year total cost, median $1,025,888.
Most frequent study sections
- Special Emphasis Panel[ZRG1 EMS-B (56)]1
Most frequent institutions
- UNIVERSITY OF OREGON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Characterizing individual responsiveness to exercise to enable engineering of mitohormetic probiotics1R61AT013374-01 · under PAR-24-238 | GUILLEMIN, KAREN J | UNIVERSITY OF OREGON, OR | $1,025,888 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.